Home › presented
 

Keywords :   


Tag: presented

Axalta Powder Coatings Expert Presented at the International Congress of Aluminum and Exposition

2016-08-19 16:00:00| Coatings World Breaking News

Tags: international presented expert congress

 

Diagnosis of fisheries and aquaculture vulnerability to climate change presented

2016-07-11 13:31:00| Climate Ark Climate Change & Global Warming Newsfeed

World News: The Ministry of Production (PRODUCE) has presented the Current Diagnosis of Fisheries and Aquaculture Sector Vulnerability to Climate Change in order to implement measures to counter the harm caused by climate, non-climate and oceanographic changes to fishing and aquaculture activities in the country. The document presented by Deputy Minister of Fisheries and Aquaculture Juan Carlos Requejo Aleman is the result of teamwork led by Rosa Zavala, PRODUCE Director General of Fisheries Sustainability...

Tags: change presented diagnosis climate

 
 

First Good Pig Awards Presented to Italian Producers

2016-07-07 02:00:00| ThePigSite - Industry News

GLOBAL - Strides in pig welfare are being made with the first full Good Pig Awards attained by Italian producers at Compassion in World Farming’s Good Farm Animal Welfare Awards and farm animal welfare may have reached a significant tipping point as food businesses from all corners of the globe were recognised at the annual awards ceremony.

Tags: good presented awards italian

 

Raccortubi Group Presented with 2016 Business International Finance Award

2016-06-29 16:00:00| Offshore Technology

On the evening of 8 June, Raccortubi was awarded the 2016 Business International Finance Award for its administrative processes, accounting and management systems.

Tags: business international group finance

 

Results of Phase 2 Study of Mercks Investigational Beta-Lactamase Inhibitor Relebactam in Combination with Imipenem/Cilastatin Presented at ASM Microbe

2016-06-20 18:30:00| Merck.com - Research & Development News

Dateline City: KENILWORTH, N.J. Pivotal Phase 3 Studies Ongoing in Treatment of Serious Bacterial Infections KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that a Phase 2 study of relebactam, the companys investigational beta-lactamase inhibitor, in combination with imipenem/cilastatin (an approved carbapenem antibiotic), in patients with complicated urinary tract infections, met its primary endpoint. Language: English Contact: MerckMedia:Pamela Eisele, (267) 305-3558orRobert Consalvo, (908) 295-0928orInvestor:Teri Loxam, (908) 740-1986orAmy Klug, (908) 740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: results study presented combination

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »